Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Am J Chin Med ; 52(2): 493-512, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38480500

RESUMEN

Eugenol (EU) has been shown to ameliorate experimental colitis due to its anti-oxidant and anti-inflammatory bioactivities. In this study, DSS-induced acute colitis was established and applied to clarify the regulation efficacy of EU on intestinal barrier impairment and macrophage polarization imbalance along with the inflammatory response. Besides, the adjusting effect of EU on macrophages was further investigated in vitro. The results confirmed that EU intervention alleviated DSS-induced colitis through methods such as restraining weight loss and colonic shortening and decreasing DAI scores. Microscopic observation manifested that EU maintained the intestinal barrier integrity in line with the mucus barrier and tight junction protection. Furthermore, EU intervention significantly suppressed the activation of TLR4/MyD88/NF-[Formula: see text]B signaling pathways and pro-inflammatory cytokines gene expressions, while enhancing the expressions of anti-inflammatory cytokines. Simultaneously, WB and FCM analyses of the CD86 and CD206 showed that EU could regulate the DSS-induced macrophage polarization imbalance. Overall, our data further elucidated the mechanism of EU's defensive effect on experimental colitis, which is relevant to the protective efficacy of intestinal barriers, inhibition of oxidative stress and excessive inflammatory response, and reprogramming of macrophage polarization. Hence, this study may facilitate a better understanding of the protective action of the EU against UC.


Asunto(s)
Colitis , Eugenol , Animales , Ratones , Eugenol/farmacología , Eugenol/uso terapéutico , Factor 88 de Diferenciación Mieloide/genética , Receptor Toll-Like 4/genética , Colitis/inducido químicamente , Colitis/tratamiento farmacológico , Proteínas Adaptadoras Transductoras de Señales , Colon , Citocinas , Macrófagos , Antiinflamatorios , Sulfato de Dextran , FN-kappa B , Ratones Endogámicos C57BL , Modelos Animales de Enfermedad
2.
Int Immunopharmacol ; 99: 108053, 2021 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-34435578

RESUMEN

Amomum longiligulare polysaccharides 1 (ALP1) was a glucosan that possessed an immune enhancement ability. However, disadvantages including short biological half-life hindered the application of ALP1. To solve these shortcomings, ALP1 was successfully prepared to nanoparticles (ALPP) with poly (lactic-co-glycolic acid) in the present study. And the optimal preparation conditions were developed by using the response surface method with a Box-Behnken design. The results showed that the encapsulation efficiency of ALPP reached a high level (79.88%) when the volume ratio of the water phase to the organic phase was 1:7, the volume ratio of the primary emulsion to the external water phase was 1:7, and the concentration of F68 was 0.7%. ALPP showed a controlled and sustained release. Meanwhile, the scanning electron microscope results showed that ALPP was a kind of nanoparticles with a diameter of 389.77 nm. In addition, the activating effect of ALPP on macrophages was studied. The results indicated that ALPP showed a better activity on promoting the RAW264.7 cells' activities and polarizing RAW264.7 cells into both M1 type and M2 type macrophages, compared to ALP1.


Asunto(s)
Amomum/química , Nanopartículas/química , Preparaciones de Plantas/inmunología , Preparaciones de Plantas/farmacología , Copolímero de Ácido Poliláctico-Ácido Poliglicólico/química , Polisacáridos/inmunología , Polisacáridos/farmacología , Animales , Frutas/química , Activación de Macrófagos/efectos de los fármacos , Macrófagos/efectos de los fármacos , Ratones , Nanopartículas/metabolismo , Tamaño de la Partícula , Fagocitosis/efectos de los fármacos , Preparaciones de Plantas/química , Preparaciones de Plantas/aislamiento & purificación , Copolímero de Ácido Poliláctico-Ácido Poliglicólico/inmunología , Copolímero de Ácido Poliláctico-Ácido Poliglicólico/farmacología , Polisacáridos/química , Polisacáridos/aislamiento & purificación , Células RAW 264.7
3.
Int Immunopharmacol ; 97: 107708, 2021 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-33915496

RESUMEN

Polysaccharides are important components of Alpiniae oxyphyllae fructus that have been shown to exhibit significant immunomodulatory activity in our previous study. However, whether and how A. oxyphyllae fructus polysaccharides (AOFP) affect macrophages has not been determined. To further study the immunomodulatory activity of AOFP, the effect of AOFP on RAW264.7 cell activation was investigated in the present work. The results showed that AOFP2 significantly increased the phagocytic activity of RAW264.7 macrophages. AOFP2 promoted the secretion of TNF-α, IL-6, IL-10, TGF-ß, NO and iNOS and enhanced the Th2-type immune response via its activation effect on macrophages. Additionally, the structure of AOFP2 was characterized in the present study, as the structural features of polysaccharides determine their biological activities. AOFP2 was only composed of glucose, exhibiting an average molecular weight of 44.3 kDa. Furthermore, the infrared spectroscopy, methylation and nuclear magnetic resonance results indicated that AOFP2 consisted of â†’ 4)-α-D-Glcp-(1→, →4,6)-α-D-Glcp-(1 â†’ and T-α-Glcp.


Asunto(s)
Alpinia/química , Factores Inmunológicos/farmacología , Macrófagos/efectos de los fármacos , Extractos Vegetales/química , Polisacáridos/farmacología , Animales , Factores Inmunológicos/química , Ratones , Peso Molecular , Polisacáridos/química , Células RAW 264.7
4.
J Ethnopharmacol ; 259: 113009, 2020 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-32450234

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: The dry overground parts of Pogostemon cablin (Blanco) Benth. is widely used in China as a traditional Chinese medicine for the treatment of diarrhea, vomiting, nausea and fever. Polysaccharide is an important component of Pogostemon cablin (Blanco) Benth. but has not been studied. Pogostemon cablin (Blanco) Benth. is used to treat porcine epidemic diarrhea. But it is not known whether Pogostemon cablin polysaccharides (PCPs) has the antiviral activities against porcine epidemic diarrhea virus (PEDV). AIM OF THE STUDY: The purpose of present study is to investigate the structural characterization and the anti-PEDV activities of PCPs. MATERIALS AND METHODS: PCPs were prepared by water extraction and alcohol precipitation method and purified with DEAE-52 cellulose column and Sephadex G-100 column. Then, the structural characterization of the polysaccharides including the infrared spectrum, molecular weight and monosaccharide composition were analyzed. Afterwards, the antiviral effect of PCPs against PEDV on IPEC-J2 cells was studied by MTT method and real-time PCR method. Additionally, the effects of PCPs on PEDV adsorption, penetration and replication were analyzed by real-time PCR method. Furthermore, we also investigate whether the anti-oxidative effects of PCPs were important to the anti-PEDV activities. RESULTS: Four polysaccharides were obtained and named as PCP1.1 (31.3 kDa), PCP1.2 (3.5 kDa), PCP2.1 (9.1 kDa) and PCP2.2 (8.3 kDa). PCP1.1, PCP1.2 and PCP2.1 were composed of fucose, arabinose, galactose, glucose, mannose, galacturonic acid and glucuronic acid; and PCP2.2 was composed of arabinose, galactose, glucose, galacturonic acid and glucuronic acid. All PCPs showed anti-PEDV activities. PCP1.1 and PCP1.2 inhibited PEDV replication, while PCP2.1 and PCP2.2 inhibited PEDV penetration and replication. All PCPs showed anti-oxidative effects, which were important to the anti-PEDV activities. CONCLUSIONS: The treatment effect of Pogostemon cablin (Blanco) Benth. on porcine epidemic diarrhea might be related to the anti-PEDV effect of PCPs. Furthermore, the anti-oxidative effects of PCPs play important roles in their antiviral activities against PEDV.


Asunto(s)
Antivirales/farmacología , Mucosa Intestinal/virología , Extractos Vegetales/farmacología , Pogostemon , Polisacáridos/farmacología , Virus de la Diarrea Epidémica Porcina/efectos de los fármacos , Animales , Antioxidantes/farmacología , Antivirales/aislamiento & purificación , Línea Celular , Mucosa Intestinal/metabolismo , Estructura Molecular , Peso Molecular , Estrés Oxidativo/efectos de los fármacos , Extractos Vegetales/aislamiento & purificación , Pogostemon/química , Polisacáridos/aislamiento & purificación , Virus de la Diarrea Epidémica Porcina/patogenicidad , Relación Estructura-Actividad , Sus scrofa
5.
Int J Biol Macromol ; 155: 927-937, 2020 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-31712145

RESUMEN

For further applications of Alpiniae oxyphyllae fructus in modern clinical medicine, Alpiniae oxyphyllae fructus polysaccharide (AOFP) was studied in the present work. The extraction conditions of AOFP were optimized by the response surface method with a Box-Behnken design. The maximum extraction rate of AOFP was 3.18%. An anion-exchange DEAE-52 cellulose column and a Sephadex G-100 gel column were used to isolate the AOFP, and three polysaccharides (AOFP1, AOFP2, AOFP3) were obtained. All three polysaccharides possessed immunoregulatory activity, but the effects of AOFP1 were greater than the other two polysaccharides. AOFP1 significantly stimulated Th1- and Th2-type immune responses and specific immune responses. Meanwhile, the characterization of AOFP1 was studied. AOFP1 was composed of arabinose, galactose, glucose, xylose, mannose, galacturonic acid, and glucuronic acid at a molar ratio of 16.46:12.7:4.9:17.11:4.35:6.52:6 with an average molecular weight of 43.4 kDa. These results suggest that AOFP1 can be developed as a natural immunomodulatory drug.


Asunto(s)
Alpinia/química , Frutas/química , Factores Inmunológicos , Extractos Vegetales , Polisacáridos , Animales , Secuencia de Carbohidratos , Células Cultivadas , Factores Inmunológicos/aislamiento & purificación , Factores Inmunológicos/farmacología , Masculino , Ratones , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/farmacología , Polisacáridos/aislamiento & purificación , Polisacáridos/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA